CS logo
small CS logo
New Orleans Center for Clinical Research

Knoxville, Tennessee, United States
Medical laboratory in Knoxville, Tennessee
1924 Alcoa Highway 4th and 5th Floors North Tower, Knoxville, TN 37920

About New Orleans Center for Clinical Research


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Pfizer
21
Bristol-Myers Squibb
8
Genentech, Inc.
7
RAI Services Company
7
Celgene
5
Gilead Sciences
5
Allergan
4
Hoffmann-La Roche
4
Janssen Research & Development, LLC
4
Novartis
4
PhaseBio Pharmaceuticals Inc.
4
Total Rows: 64

Clinical Trials at New Orleans Center for Clinical Research


During the past decade, New Orleans Center for Clinical Research conducted 72 clinical trials. In the 10-year time frame, 72 clinical trials started and 60 clinical trials were completed, i.e. on average, 83.3% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 33 clinical trials were completed. i.e. 366.7% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years10101010141415151414663322443355131314141212Started TrialsCompleted Trails201520162017201820192020202105101520
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Safety and Efficacy of a Monoclonal Antibody for Treatment of Rheumatoid Arthritis.
2002-04-01
2003-08-01
Completed
Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus
2002-05-01
2003-08-01
Completed
734
Evaluation of the Bioavailability of Pramlintide
2002-06-01
2002-12-01
Completed
75
Safety and Efficacy Study of Once and Twice Daily Doses of MCC-135 in Subjects With Congestive Heart Failure.
2002-08-01
2003-08-01
Completed
204
Safety and Efficacy Study of YM087 (Conivaptan) in Patients With Acute Decompensated Heart Failure
2002-11-01
2004-03-01
Completed
170
Determine the Safety and Efficacy of (R,R)-Formoterol in the Treatment of Subjects With COPD
2002-04-01
2004-03-01
Completed
741
To Evaluate the Long-term Safety of (R,R)-Formoterol in Subjects With COPD
2002-06-01
2004-12-01
Completed
799
Trial of VLTS-589 in Subjects With Intermittent Claudication
2003-06-01
2005-06-01
Completed
100

Rows per page:

1–100 of 149

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "New Orleans Center for Clinical Research" #1 sponsor was "Pfizer" with 21 trials, followed by "Bristol-Myers Squibb" with 8 trials sponsored, "Genentech, Inc." with 7 trials sponsored, "RAI Services Company" with 7 trials sponsored and "Celgene" with 7 trials sponsored. Other sponsors include 96 different institutions and companies that sponsored additional 64 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "New Orleans Center for Clinical Research" #1 collaborator was "Celerion" with 3 trials as a collaborator, "Pfizer" with 3 trials as a collaborator, "CoLucid Pharmaceuticals" with 2 trials as a collaborator, "Covance" with 2 trials as a collaborator and "Bavarian Nordic" with 1 trials as a collaborator. Other collaborators include 8 different institutions and companies that were collaborators in the rest 18 trials.
Created with Highcharts 11.1.0Top Leading SponsorsPfizer: 21Pfizer: 21Bristol-Myers Squibb: 8Bristol-Myers Squibb: 8Genentech, Inc.: 7Genentech, Inc.: 7RAI Services Company: 7RAI Services Company: 7Celgene: 5Celgene: 5Gilead Sciences: 5Gilead Sciences: 5Allergan: 4Allergan: 4Hoffmann-La Roche: 4Hoffmann-La Roche: 4Janssen Research &Development, LLC: 4Janssen Research &Development, LLC: 4Novartis: 4Novartis: 4

Created with Highcharts 11.1.0Top CollaboratorsCelerion: 3Celerion: 3Pfizer: 3Pfizer: 3CoLucid Pharmaceuticals: 2CoLucid Pharmaceuticals: 2Covance: 2Covance: 2Bavarian Nordic: 1Bavarian Nordic: 1Biomedical AdvancedResearch andDevelopment Authority:1Biomedical AdvancedResearch andDevelopment Authority:1ClinPhone, Inc.: 1ClinPhone, Inc.: 1Dainippon SumitomoPharma America: 1Dainippon SumitomoPharma America: 1Eli Lilly and Company: 1Eli Lilly and Company: 1Emergent BioSolutions: 1Emergent BioSolutions: 1

Clinical Trials Conditions at New Orleans Center for Clinical Research


According to Clinical.Site data, the most researched conditions in "New Orleans Center for Clinical Research" are "Alzheimer's Disease" (7 trials), "Tobacco Use" (7 trials), "Smoking" (6 trials), "Migraine, With or Without Aura" (5 trials) and "Chronic Obstructive Pulmonary Disease" (4 trials). Many other conditions were trialed in "New Orleans Center for Clinical Research" in a lesser frequency.

Clinical Trials Intervention Types at New Orleans Center for Clinical Research


Most popular intervention types in "New Orleans Center for Clinical Research" are "Drug" (120 trials), "Other" (18 trials), "Biological" (17 trials), "Device" (4 trials) and "Behavioral" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (54 trials), "Rimegepant" (4 trials), "placebo" (4 trials), "Salmeterol" (3 trials) and "AC2993" (2 trials). Other intervention names were less common.

Clinical Trials Genders at New Orleans Center for Clinical Research


The vast majority of trials in "New Orleans Center for Clinical Research" are 133 trials for "All" genders, 8 trials for "Female" genders and 8 trials for "Male" genders.

Clinical Trials Status at New Orleans Center for Clinical Research


Currently, there are NaN active trials in "New Orleans Center for Clinical Research". undefined are not yet recruiting, 5 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 129 completed trials in New Orleans Center for Clinical Research, undefined suspended trials, and 10 terminated clinical trials to date.
Out of the total trials that were conducted in New Orleans Center for Clinical Research, 44 "Phase 1" clinical trials were conducted, 42 "Phase 2" clinical trials and 47 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 8 trials, and there were also 12 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 47Phase 3: 47Phase 1: 44Phase 1: 44Phase 2: 42Phase 2: 42Not Applicable: 12Not Applicable: 12Phase 4: 8Phase 4: 8Early Phase 1: 1Early Phase 1: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 129Completed: 129Terminated: 10Terminated: 10Recruiting: 5Recruiting: 5Active, not recruiting: 2Active, not recruiting: 2Unknown status: 2Unknown status: 2Withdrawn: 1Withdrawn: 1